Xencor

Pfenex Biopharm Aceuticals is a biotechnology company based in San Diego, CA, specializing in the development and production of innovative biopharmaceuticals. With a focus on cutting-edge research and technology, the company is dedicated to advancing healthcare through the creation of high-quality, cost-effective therapeutic products. Generated from their business information

Zenobia Therapeutics Inc is a San Diego-based company specializing in fragment-based lead discovery for the development of treatments for neurodegenerative diseases. With a focus on the central nervous system (CNS), their products and services have successfully yielded hits for a diverse range of targets worldwide. Founded in 2008, Zenobia Therapeutics expanded in 2014 to include Zenobia Fragments, a division dedicated to supplying highly core diverse fragments and unique reagents for protein solubilization and crystallization. Complementing their product offerings, Zenobia also provides screening and structural biology services to support fragment library purchases, solidifying their position as a leader in fragment-based lead discovery and CNS disease research.Generated from the website

Targacept is a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat diseases and disorders of the central nervous system. It is a leader in the field of neuronal nicotinic acetylcholine receptor chemistry and biology. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity. Targacept s product candidates are designed to selectively target specific NNR subtypes and promote therapeutic effects and limit adverse side effects. Targacept has product candidates in clinical development for cognitive impairment, including Alzheimer s disease and age-associated memory impairment, pain and depression. From 1997 to 2000, Targacept was a subsidiary of R. J. Reynolds Tobacco Company. During this time, the company s investigations into the biological effects of nicotine suggested a role for NNRs in the treatment of human disease and led to the creation of Targacept.